GGrantIndex
← Leaderboards

Kathryn Baughman

Sri International

Google Scholar ↗PubMed ↗ORCID ↗
$29,412,662
Attributed
$29,412,662
Total exposure
14
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $9.1M · FY2011–19
$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$29,412,662 · 14

By mechanism

N01$29,411,162 · 13
N03$1,500 · 1

Top collaborators

No co-investigators on record.

Most similar at Sri International

Same institution · by research overlap

Others in their field

Top investigators on “Contracts”

Research focus

ContractsProgramsBiological TestingContraceptive AgentsServicesNational Institute Of Child Health And Human DevelopmentDrug KineticsSafetyPharmaceutical PreparationsContractorResearch PersonnelPre-ClinicalEvaluationDesignToxicologyResourcesEquipmentClinical TrialsPharmacologic SubstanceWomanPharmacology And ToxicologyFormulationAnimalsGood Laboratory Practice

Grant awards (52)

BIOLOGICAL TESTING FACILITY - MAINTENANCE OF EXISTING NON-HUMAN PRIMATE COLONY$315,898
N01 · FY2019 · HD · contact PI
BIOLOGICAL TESTING FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE$301,244
N01 · FY2019 · HD · contact PI
Preclinical Development Services for AIDS Therapeutics$245,250
N01 · FY2019 · AI · contact PI
BIOLOGICAL TESTING FACILITY - MAINTENANCE OF EXISTING NON-HUMAN PRIMATE COLONY$1,041,995
N01 · FY2018 · HD · contact PI
BIOLOGICAL TESTING FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE$864,893
N01 · FY2018 · HD · contact PI
Preclinical Development Services for AIDS Therapeutics$244,390
N01 · FY2018 · AI · contact PI
IGF::OT::IGF SMARTT PHARMACOLOGY AND TOXICOLOGY CENTER (PTC); BASE PERIOD; FY16; AMT $1,653,316; CAN 8470205$1,406,438
N01 · FY2017 · HL · contact PI
IGF::OT::IGF SMARTT NON-BIOLOGICS AND SMALL MOLECULE PF; BASE PERIOD; FY16; AMT $ 1,175,069; CAN 8470205$1,275,900
N01 · FY2017 · HL · contact PI
BIOLOGICAL TESTING FACILITY - MAINTENANCE OF EXISTING NON-HUMAN PRIMATE COLONY$890,602
N01 · FY2017 · HD · contact PI
BIOLOGICAL TESTING FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE$682,698
N01 · FY2017 · HD · contact PI
BIOLOGICAL TESTING FACILITY - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVES$393,572
N01 · FY2017 · HD · contact PI
GENERAL ADMINISTRATIVE AND TECHNICAL SUPPORT$243,556
N01 · FY2017 · AI · contact PI
IGF::OT::IGF:PHARMACOKINETICS AND TOXICOLOGY STUDIES:IND - ENABLING STUDIES - WAGNER LTD 9/15/16-9/14/17$194,124
N01 · FY2017 · MH · contact PI
BIOLOGICAL TESTING FACILITY - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVES$170,002
N01 · FY2017 · HD · contact PI
IGF::OT::IGF:PHARMACOKINETICS AND TOXICOLOGY STUDIES - BUCKPITT LDT,$50,990
N01 · FY2017 · MH · contact PI
Pharmacology and Toxicology for Neurotherapeutics Program-KENNY LDT$21,669
N01 · FY2017 · MH · contact PI
IGF::OT::IGF SMARTT PHARMACOLOGY AND TOXICOLOGY CENTER (PTC); BASE PERIOD; FY16; AMT $1,653,316; CAN 8470205$1,653,340
N01 · FY2016 · HL · contact PI
IGF::OT::IGF:PHARMACOKINETICS AND TOXICOLOGY STUDIES:IND - ENABLING STUDIES - WAGNER LTD 9/15/16-9/14/17$1,415,289
N01 · FY2016 · MH · contact PI
BIOLOGICAL TESTING FACILITY - CLINICAL DEVELOPMENT AND FORMULATION OPTIMIZATION OF NEW PRODUCTS OR DEVICES FOR CONTRACEPTIVE METHODS$1,397,947
N01 · FY2016 · HD · contact PI
IGF::OT::IGF SMARTT NON-BIOLOGICS AND SMALL MOLECULE PF; BASE PERIOD; FY16; AMT $ 1,175,069; CAN 8470205$1,175,069
N01 · FY2016 · HL · contact PI
BIOLOGICAL TESTING FACILITY - MAINTENANCE OF EXISTING NON-HUMAN PRIMATE COLONY$910,481
N01 · FY2016 · HD · contact PI
BIOLOGICAL TESTING FACILITY - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVES$759,924
N01 · FY2016 · HD · contact PI
Pharmacology and Toxicology for Neurotherapeutics Program-KENNY LDT$719,630
N01 · FY2016 · MH · contact PI
IGF::OT::IGF:PHARMACOKINETICS AND TOXICOLOGY STUDIES - BUCKPITT LDT,$352,781
N01 · FY2016 · MH · contact PI
BIOLOGICAL TESTING FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE$327,051
N01 · FY2016 · HD · contact PI
IGF::OT::IGF GENERAL ADMINISTRATIVE AND TECHNICAL SUPPORT$242,752
N01 · FY2016 · AI · contact PI
IGF::OT::IGF: RODENT PHARMACOKINETIC AND BRAIN LEVEL DETERMINATION - PERIOD OF PERFORMANCE 9/15/2016-9/14/2017$116,397
N01 · FY2016 · MH · contact PI
IGF::OT::IGF:CONTRACT ADMINISTRATION - PERIOD OF PERFORMANCE 9/13/2016-9/12/2017$32,405
N01 · FY2016 · MH · contact PI
IGF::OT::IGF INITIAL ADMINISTRATIVE CHARGES TO#1 PRE-CLIN TOX STUDY OF DRUG DEV FOR CANCER PATIENTS HHSN261201600017I DTP-16-043 TPB$1,500
N03 · FY2016 · CA · contact PI
BIOLOGICAL TESTING FACILITY - FORMULATION, SUPPLY, AND STABILITY TESTING OF CONTRACEPTIVE DRUG CANDIDATES FOR CLINICAL TESTING$1,745,047
N01 · FY2015 · HD · contact PI
BIOLOGICAL TESTING FACILITY - MAINTENANCE OF EXISTING NON-HUMAN PRIMATE COLONY$910,481
N01 · FY2015 · HD · contact PI
BIOLOGICAL TESTING FACILITY - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVES$720,748
N01 · FY2015 · HD · contact PI
IGF::OT::IGF 2015-E03B/OVARIAN CANCER CHEMOPREVENTION (SHETA2) PERIOD OF PERFORMANCE 09/24/2015 - 09/23/2017$509,357
N01 · FY2015 · CA · contact PI
BIOLOGICAL TESTING FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE$321,664
N01 · FY2015 · HD · contact PI
BIOLOGY TESTING FACILITY - BIOINFORMATICS/LITERATURE DATA-MINING TO ESTABLISH CONTRACEPTIVE DRUG TARGET PROFILE$301,906
N01 · FY2015 · HD · contact PI
IGF::OT::IGF GENERAL ADMINISTRATIVE AND TECHNICAL SUPPORT$241,991
N01 · FY2015 · AI · contact PI
BIOLOGICAL TESTING FACILITY - PRECLINICAL DEVELOPMENT$871,395
N01 · FY2014 · HD · contact PI
BIOLOGICAL TESTING FACILITITY - MANAGEMENT, ADMINISTRATION, DATABASE & TRANSITION ACTIVITIES$589,988
N01 · FY2014 · HD · contact PI
BIOLOGICAL TESTING FACILITY - CONTRACEPTIVE TESTING OF LEVONORGESTREL BUTANOATE (LNG-B)$568,987
N01 · FY2014 · HD · contact PI
IGF::OT::IGF GENERAL ADMINISTRATIVE AND TECHNICAL SUPPORT$241,235
N01 · FY2014 · AI · contact PI
IGF::OT::IGF "Rodent Pharmacokinetic and Brain Level Determination"$150,834
N01 · FY2014 · MH · contact PI
IGF::OT::IGF FORMULATION DEVELOPMENT AND EVALUATION STUDIES OF METHOTREXATE, NEVIRAPINE, SUTEZOLID, LEVOFLOXACIN, AND RUXOLITNIB$122,354
N01 · FY2014 · AI · contact PI
Investigational New Drug Toxicology for Drugs to Treat Alzheimer's Disease and Ot$1,251,210
N01 · FY2013 · AG · contact PI
MGT SVCS/CONTRACT & PROCUREMENT SUP$556,723
N01 · FY2013 · DA · contact PI
MGT SVCS/CONTRACT & PROCUREMENT SUP$419,674
N01 · FY2013 · DA · contact PI
Investigational New Drug Toxicology for Drugs to Treat Alzheimer's Disease and Ot$95,256
N01 · FY2013 · AG · contact PI
MGT SVCS/CONTRACT & PROCUREMENT SUP$56,884
N01 · FY2013 · DA · contact PI
BIOLOGICAL TESTING FACILITY - CDB-4754$823,583
N01 · FY2011 · HD · contact PI
BIOLOGICAL TESTING FACILITY FOR CRH$509,087
N01 · FY2011 · HD · contact PI
CDB-4754 (11 b-MNTDC) FORMULATION PREPARATION$421,232
N01 · FY2011 · HD · contact PI
CDB-4776/H2-GAMENDAZOLE 28-DAY DEFINITIVE TOXICOLOGY IN NON RODENT$305,239
N01 · FY2011 · HD · contact PI
BIOLOGICAL TESTING FACILITY - CDB-2914 OR RELATED COMPOUND, MOUSE/RAT/RABBIT TO$230,000
N01 · FY2011 · HD · contact PI